DiaSorin (DSRLF)
(Delayed Data from OTC)
$94.25 USD
-5.75 (-5.75%)
Updated Sep 12, 2025 10:52 AM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
DSRLF 94.25 -5.75(-5.75%)
Will DSRLF be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for DSRLF based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for DSRLF
DiaSorin just upgraded at UBS, here's why
DiaSorin initiated with bearish view at JPMorgan, here's why
DiaSorin just upgraded at Morgan Stanley, here's why
Qiagen: Diagnostics Vs. Life Sciences Pair Trade Analysis
Bruker: Former Academia Customer Strength, Now Incredible Weakness